Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles
Status:
Not yet recruiting
Trial end date:
2027-09-01
Target enrollment:
Participant gender:
Summary
The development of stimulation protocols for in vitro fertilisation (IVF) has led to a
paradox. It has now been established that obtaining a large number of oocytes is a key to
success, but that it is also a risk factor for embryo transfer failure after puncture
(disruption of endometrial receptivity due to luteal insufficiency) and a risk factor for
complications such as ovarian hyperstimulation syndrome (OHSS).